Ceftolozane-tazobactam activity against drug-resistant Enterobacteriaceae and Pseudomonas aeruginosa causing healthcare-associated infections in Latin America: report from an antimicrobial surveillance program (2013–2015)

This study evaluated the in vitro activity of ceftolozane-tazobactam and comparator agents tested against Latin American isolates of Enterobacteriaceae and Pseudomonas aeruginosa from patients with health care-associated infections. Ceftolozane-tazobactam is an antipseudomonal cephalosporin combined...

Descripción completa

Detalles Bibliográficos
Autores principales: Pfaller, Michael A., Shortridge, Dee, Sader, Helio S., Gales, Ana, Castanheira, Mariana, Flamm, Robert K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2017
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9425460/
https://www.ncbi.nlm.nih.gov/pubmed/28941394
http://dx.doi.org/10.1016/j.bjid.2017.06.008

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9425460/
https://www.ncbi.nlm.nih.gov/pubmed/28941394
http://dx.doi.org/10.1016/j.bjid.2017.06.008

Ejemplares similares